Cite
HARVARD Citation
Boysen Fynboe Ebert, E. et al. (2020). Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients. Lung cancer. pp. 67-72. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Boysen Fynboe Ebert, E. et al. (2020). Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients. Lung cancer. pp. 67-72. [Online].